Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences

• Main Authors: Sabrina Chiloiro (Author), Marialuisa Appetecchia (Author), Antonio Bianchi (Author), Denise Costa (Author), Christine De Acetis (Author), Patrizia Gargiulo (Author), Antonella Giampietro (Author), Andrea M Isidori (Author), Marie-Lise Ja (Author), Marina Passeri (Author), Francesca Pigliaru (Author), Maurizio Poggi (Author), Laura De Marinis (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pasireotide-LAR is recommended as a second-line treatment for patients with acromegaly. Although the effects of pasireotide-LAR have been well characterized in clinical studies, real-practice evidence is scant, especially in the long term and within the individualization of therapy in patients with...